Magnolol and Honokiol: Inhibitors against Mouse Passive Cutaneous Anaphylaxis Reaction and Scratching Behaviors
RBL-2H3 cells (5ϫ10 5 cells), previously cultured in DMEM, were treated with 0.5 mg/ml mouse monoclonal IgE for sensitization of the cells for 24 h. The cells (0.32 ml) were exposed to 0.04 ml of the test agents (dissolved in 0.5% dimethyl sulfoxide) with 0.04 ml of DNP-HSA (1 mg/ml) for 4 h at 37°C. The supernatant (50 ml) was transferred into 96-well ELISA plates, and the IL-4 and TNF-a concentrations then determined using commercial ELISA Kits (Pierce Biotechnology, Inc., Rockford, IL, U.S.A.).
13)
Animals The male ICR and BALB/c mice (20-25 g) were supplied by the Orient Experimental Animal Breeding Center (Seoul, Korea). All animals were housed in wire cages, maintained at 20-22°C and 50Ϯ10% humidity, fed standard laboratory chow (Orient Experimental Animal Breeding Center) and allowed water ad libitum. All procedures relating to the animals and their care conformed to the international guidelines: Principles of Laboratory Animals Care (NIH publication no. 85-23, revised 1985) .
Measurement of PCA Reaction An IgE-dependent cutaneous reaction was measured according to the previous method of Choo et al. 12) The male ICR mice were intradermally injected, with 10 mg of anti-DNP IgE, into each of two dorsal skin sites that had been shaved 48 h earlier. The sites were outlined with a water-insoluble red marker. Forty-eight hours later each mouse received an injection of 200 ml of 3% Evans blue in PBS, containing 200 mg of DNP-HSA, via the tail vein. The test agents were orally administered 1 h prior to the DNP-HSA injection. Thirty minutes after the DNP-HSA injection, the mice were sacrificed, their dorsal skins removed and the pigmented area measured. After extraction with 1 ml 1.0 M KOH and 4 ml of a mixture of acetone and 0.2 M phosphoric acid (13 : 5), the amount of dye was determined colorimetrically at 620 nm.
Assay of Scratching Behavior Frequency
The scratching behavioral experiment in male BALB/c mice was performed according to the method of Sugimoto et al. 14) Male BALB/c mice were put into acrylic cages (22ϫ22ϫ24 cm) for about 10 min for acclimation. The rostral part of the skin on the back of mice was clipped, and 50 mg/50 ml of compound 48/80 for each mouse was intradermally injected. The compound 48/80 was dissolved in saline and then used. Control mice received a saline injection in the place of the compound 48/80. Immediately after the intradermal injection, the mice (one animal/cage) were put back into the same cage and, for the observation of scratching; their behaviors recorded using an 8-mm video camera (SV-K80, Samsung, Seoul, Korea) under unmanned conditions. Scratching of the injected site by the hind paws was counted and compared with that of other sites, such as the ears. Each mouse was used for only one experiment. The mice generally showed several scratches for 1 s, and a series of these behaviors was counted as one incident of scratching for 60 min. The test agents (dissolved in 2% cremophor EL) were orally administered 1 h before the scratching agent.
Statistical Analysis All data are expressed as the meanϮstandard deviation, and statistical significance was analyzed using a one way ANOVA, followed by a StudentNewman-Keuls test.
RESULTS AND DISCUSSION
The inhibitory effects of magnolol and honokiol, isolated from MO, against the PCA reaction induced in mice by an intradermal injection of anti-DNP-HSA was measured (Table  1) . Of these two compounds, magnolol potently inhibited the PCA reaction, with the inhibition by honokiol being slightly less potent. Magnolol, at a dose of 50 mg/kg, was found to inhibit the PCA reaction by 52% compared to that of the control group. These agents also inhibited the scratching behaviors induced by compound 48/80. Magnolol, at a dose of 50 mg/kg, was found to inhibit the scratching behavior frequency by 40% compared to that of the control group. Magnolol was found to be a more potent inhibitor than honokiol.
To understand the antiallergic effects of magnolol and honokiol, their degranulation-inhibitory activities against the degranulation of RBL-2H3 cells, induced by the IgE-antigen complex, were measured ( Table 2 ). These agents potently inhibited the degranulation of RBL-2H3 cells, with IC 50 values of 45 and 55 mM, respectively. Their inhibitory activities were comparable with that of azelastine (IC 50 ϭ35 mM). When the effects of magnolol and honokiol on the protein expressions of IgE-inducing IL-4 and proinflammatory TNF-a in RBL-2H3 cells were investigated, using ELISA analysis, both compounds, at a dose of 50 mM, inhibited the expressions by 31.6 and 28.1%, and 44.6 and 48.5%, respectively (Fig. 2) . Magnolol and honokiol also inhibited the activation of NFkB, which regulates protein expression of proinflammatory cytokines (data not shown) like the previous reported.
15) The a) The passive cutaneous anaphylaxis reaction in mice was induced by an intradermal injection of anti-DNP-HSA. The test agents were orally administered 60 min prior to challenge with the DNP-HSA antigen. The amounts of extravasated Evan blue from the dorsal skin (1ϫ1 cm) of the control stimulated with the IgE-antigen complex and vehicle-treated groups were 25Ϯ3 and 12Ϯ2 mg, respectively. b) Scratching behavior frequency numbers of normal control, which was treated with saline alone, and control group, which was treated with compound 48/80 and saline, for 1 h were 245Ϯ16 and 3Ϯ2, respectively. Values are expressed as the meansϮS.D. (nϭ5).
c,d,e,f Items with the same letter in each column were not significantly different. inhibitory effects of magnolol against these protein expressions were more potent than those of honokiol.
Antihistamine agents, such as azelastine, steroids, such as betamethasone valerate, and immunosuppressants, such as cyclosphorin A, are valuable antiallergic drugs. [16] [17] [18] However, these agents have side effects, such as anticholinergic effects, skin atrophy and nephrotoxicity. Therefore, new agents for clinical uses have been developed from traditional Chinese medicines. 19) In the present study, magnolol and honokiol inhibited the PCA reaction induced by IgE and the scratching behavior induced by compound 48/80 in vivo. These constituents inhibited the degranulation and proinflammatory and IgE-inducing cytokine biosynthesis of RBL-2H3 cells induced by IgE-antigen complex. These constituents also repressed the activation of NF-kB, which is the transcription factor of proinflammatory cytokines. In the previous study, Hamasaki et al. 9) reported that magnolol inhibits leukotriene synthesis in RBL-2H3 cells. Lee et al. 15) also reported that magnolol and honokiol exhibit anti-inflammatory effect through the inhibition of NF-kB activation. These results suggest that magnolol and honokiol may regulate the proinflammatory cytokine biosynthesis of RBL-2H3 cells by the inhibition of transcription factor NF-kB activation. Ko et al. 20) reported that magnolol and honokiol inhibit Ca 2ϩ -dependent tracheal smooth muscle constraction.
Based on these findings, magnolol and honokiol may regulate the degranulation, as well as the cytokine biosynthesis, of mast cells and basophils, which may improve IgE-induced allergic diseases, such as anaphylaxis, rhinitis, asthma and atopic dermatitis.
